Clinical studies examining the potential of CT exposure to cause cancer are under way, but it could be years or even a decade until the results are known. Even then, they may be inconclusive, say expert presenters at the ISCT symposium on MDCT.
Clinical studies examining the potential of CT exposure to cause cancer are under way, but it could be years or even a decade until the results are known. Even then, they may be inconclusive, say expert presenters at the ISCT symposium on MDCT.
Dr. Andrew J. Einstein, an assistant professor of clinical medicine in radiology at Columbia University, examined the current basis for concerns about radiation exposure from CT, noting that none of the research used to support these cautionary arguments involve CT radiation exposure itself. Instead they are drawn from studies examining survivors of the atomic bombing of Hiroshima, accidents involving nuclear power plant workers, and exposure of children to radiation in utero.
A half dozen clinical studies are now enrolling hundreds of thousands of patients in Canada, the U.K., Australia, Israel, Sweden, and France with the goal of looking specifically at whether CT is a cause of cancer. But the studies, one of which involves pediatric patients, will take many years to complete. And there is no guarantee the results will be definitive.
“But it is still important that we do such studies because each additional study provides us with new information and a more complete picture of the issues that we are dealing with,” Einstein said.
In the meantime, the CT community and public will be left with only circumstantial data to make or break the connection between CT exams and cancer, a prospect that concerns Cynthia H. McCollough, Ph.D., director of the CT Clinical Innovation Center at Mayo Clinic College of Medicine.
Some patients are making bad decisions about their healthcare because of their unjustified fear of CT radiation, McCollough said, promulgated by a flawed base of research data. Despite 60 years of studying the Hiroshima data, for example, no definitive conclusions have yet been made about the cancer risk at doses commonly encountered during CT studies.
“When people say we just don't know what's happening, I disagree,” she said. “We know that it is not a big effect . If it is an effect at all, it is a really small effect.”
McCollough has a simple solution to the debate over radiation dose and CT, as it relates to deciding whether to schedule an exam.
“If the CT is needed, do it,” she said. “And if it's not needed, don't do it.”
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.